Pro-Dex (NASDAQ:PDEX) Stock Price Passes Above 200 Day Moving Average – Should You Sell?

Shares of Pro-Dex, Inc. (NASDAQ:PDEX) passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $38.09 and traded as high as $50.06. Pro-Dex shares last traded at $48.98, with a volume of 30,677 shares traded.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a “hold (c)” rating on shares of Pro-Dex in a research report on Monday, December 29th. One research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, Pro-Dex has an average rating of “Moderate Buy” and a consensus target price of $56.00.

Pro-Dex Stock Down 0.6%

The business’s 50-day moving average is $43.22 and its two-hundred day moving average is $38.09. The firm has a market capitalization of $157.23 million, a price-to-earnings ratio of 14.41 and a beta of -0.04. The company has a debt-to-equity ratio of 0.19, a quick ratio of 2.25 and a current ratio of 4.03.

Pro-Dex (NASDAQ:PDEX) last issued its quarterly earnings data on Thursday, January 29th. The medical instruments supplier reported $0.66 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.59 by $0.07. Pro-Dex had a net margin of 15.73% and a return on equity of 22.53%. The firm had revenue of $18.66 million during the quarter, compared to analysts’ expectations of $17.30 million. On average, equities analysts anticipate that Pro-Dex, Inc. will post 2 earnings per share for the current year.

Institutional Trading of Pro-Dex

A number of large investors have recently made changes to their positions in the company. Police & Firemen s Retirement System of New Jersey acquired a new stake in Pro-Dex during the 2nd quarter worth $28,000. Los Angeles Capital Management LLC acquired a new position in Pro-Dex in the fourth quarter valued at about $37,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new position in Pro-Dex in the second quarter valued at about $50,000. Bank of America Corp DE increased its holdings in shares of Pro-Dex by 173.3% in the second quarter. Bank of America Corp DE now owns 1,692 shares of the medical instruments supplier’s stock worth $74,000 after acquiring an additional 1,073 shares in the last quarter. Finally, AlphaQuest LLC bought a new stake in shares of Pro-Dex in the third quarter worth about $71,000. Institutional investors own 15.28% of the company’s stock.

About Pro-Dex

Pro-Dex, Inc is a designer and manufacturer of precision drive systems and fluid management products serving the dental, medical, industrial and energy markets. The company specializes in high-speed, brushless micromotors and controllers, as well as pneumatic and fluid control devices, providing both standard and custom-engineered solutions for original equipment manufacturers.

Its product portfolio includes high-speed dental handpieces, turbine systems, rotary and reciprocating micro-drives, along with integrated fluid delivery systems.